Abstract
Objective
To study the relationship between cytokine levels and cardiac troponin I (cTnI).
Design
Prospective experimental study.
Setting
Intensive care unit of a university hospital.
Participants
Six healthy male volunteers.
Interventions
Endotoxin, 4 ng/kg, was given as a 1-min intravenous infusion.
Measurements and results
Circulating cardiac troponin I levels and proinflammatory cytokines tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8) were analysed at various time points during a 24-h period. TNF-α appeared in the circulation 30 min after injection (T=0.5 h), reaching peak levels (5,665±1,910 pg/ml) 2 h after infusion. At T=24 h TNF-α was still elevated in the circulation compared to T=0. None of the six volunteers had a cTnI value higher than 0.1 μg/l at T=0, 6 h or 24 h.
Conclusion
The presence of significant amounts of TNF-α, IL-6 and IL-8 in the systemic circulation does not lead to increased levels of cTnI in experimental human endotoxaemia.
References
Adams JE III, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS (1993) Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88:101–106
Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS (1995) Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 41:1710–1715
Wu AH, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, Bodor G (1998) Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 44:1198–1208
Ammann P, Fehr T, Minder EI, Gunter C, Bertel O (2001) Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27:965–969
Turner A, Tsamitros M, Bellomo R (1999) Myocardial cell injury in septic shock. Crit Care Med 27:1775–1780
Ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK (2000) Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 46:650–657
Guest TM, Ramanathan AV, Tuteur PG, Schechtman KB, Ladenson JH, Jaffe AS (1995) Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 273:1945–1949
Fijen JW, Muller Kobold AC, de Boer P, Jones CR, van der Werf TS, Tervaert JW, Zijlstra JG, Tulleken JE (2000) Leukocyte activation and cytokine production during experimental human endotoxemia. Eur J Intern Med 11:89–95
Ver Elst KM, Chapelle JP, Boland P, Demolder JS, Gorus FK (1999) Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay. Am J Clin Pathol 112:745–752
Fernandes CJ Jr, Akamine N, Knobel E (1999) Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 25:1165–1168
Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, Gandini C (2000) Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 26:31–37
Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE (1996) Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949–958
Wu AH (2001) Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 27:959–961
Beranek JT (2002) Cardiomyocyte apoptosis contributes to the pathology of the septic shock heart. Intensive Care Med 28:218
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Bockel, E.A.P., Tulleken, J.E., Muller Kobold, A.C. et al. Cardiac troponin I release and cytokine response during experimental human endotoxaemia. Intensive Care Med 29, 1598–1600 (2003). https://doi.org/10.1007/s00134-003-1893-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1893-x